Previous 10 | Next 10 |
Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million Canada NewsWire VANCOUVER, May 16, 2019 NASDAQ, TSX: NVCN VANCOUVER , May 16, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN...
Upon closing of this agreement, cash and cash equivalents is expected to support operations into Q1 2020 NASDAQ, TSX: NVCN VANCOUVER , May 14, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally inv...
Neovasc Inc. (NVCN) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Jeremy Feffer - Investor Relations Fred Colen - President & Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Dylan Gantley - SVB L...
Neovasc (NASDAQ: NVCN ): Q1 GAAP EPS of -$0.21 misses by $0.14 . Revenue of $0.59M (+73.5% Y/Y) beats by $0.06M . Press Release More news on: Neovasc Inc., Earnings news and commentary, Healthcare stocks news, ,
NASDAQ, TSX: NVCN Recent Highlights Announced the 1,000 th recipient of a Neovasc Reducer TM ("Reducer") implant Company sponsored Reducer Symposium attended by over 100 attendees at the 85th Annual Conference of the German Society of Cardiology ("DGK") Completed the conceptu...
Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™ Canada NewsWire VANCOUVER, May 6, 2019 NASDAQ, TSX: NVCN VANCOUVER , May 6, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the ...
Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th Canada NewsWire VANCOUVER, May 3, 2019 Conference Call Scheduled for 4:30 pm Eastern Time on May 9 th NASDAQ, TSX: NVCN VANCOUVER , May 3, 2019 /CNW/ - Neovasc, Inc. ("Neovasc...
Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer Canada NewsWire VANCOUVER, April 26, 2019 NASDAQ, TSX: NVCN VANCOUVER , April 26, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or t...
Neovasc (NASDAQ: NVCN ) has agreed to settle the remaining litigation with Edwards Lifesciences (NYSE: EW ) over three patents covering CardiAQ, adding two CardiAQ employees as co-inventors, the same remedy that was agreed to regarding an earlier patent. More news on: Neovasc Inc., Edwar...
Neovasc Announces Resolution of Last Remaining Active Litigation Canada NewsWire VANCOUVER, April 17, 2019 NASDAQ, TSX: NVCN VANCOUVER , April 17, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of min...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...